About Brunel
Brunel is a Healthcare company based in Centurion (South Africa) founded in 1974 by Louis Nel and Dawie De Bruin. Diversified drugs are distributed by Brunel in South Africa. It operates on a Reseller / Distribution and B2B2C model. Its chief executive, as recorded, is Paul Jonker. Its website brunel.co.za draws about 16 thousand monthly visits. Brunel offers products and services including Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets. Its focus areas include Pharmaceuticals and General Pharmaceuticals. Its legal entity is Brunel Laboratoria (Pty) Ltd. Its competitors include Activo Health, Rand Pharmaceutical Distributors and Anmarate.
Company details
Brunel Laboratoria is established as a privately owned pharmaceutical company based in South Africa. The company is engaged in the production, distribution, and management of a wide range of healthcare brands and products. Solutions are provided across sectors including oral health, haircare, eye care, vitamins, sun protection, and probiotics. A custom-built distribution center is utilized to ensure efficient delivery from manufacturer to client. With over five decades of expertise, strategic partnerships are maintained to uphold quality and compliance in the supply chain.
- Headquarters Centurion, South Africa
- Founders Louis Nel, Dawie De Bruin
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website brunel.co.za
- Social LinkedIn Facebook
- Legal Name Brunel Laboratoria (Pty) Ltd
- InvestorsRMB Corvest
& 2 more
Products & Services of Brunel
Brunel offers a comprehensive portfolio of products and services, including Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets.
Various healthcare products are offered for diverse needs.
Packaging materials are provided for pharmaceutical products.
Cardiovascular tablets are included in the portfolio.
Funding Insights of Brunel
- Total Rounds 1
- Investors Count 3
All 1 funding rounds of Brunel with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2022 | Private Equity Round | – | – |
3 investors in total: 3 institutional.
Investors in Brunel
Brunel has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include RMB Corvest, Calibre Capital and Umoya Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
PE firm investing in South Africa | rmbcorvest.co.za | Kingsburgh, South Africa | ||
Umoya Capital Partners is engaged in providing investment capital to private businesses. | umoyacapital.co.za | Bryanston, South Africa | ||
Offers investment management services focused on portfolio construction and risk assessment. | 2002 | calibrecapital.co | Pretoria, South Africa |
Investor details for Brunel
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Brunel
3 people are tracked at Brunel (3 in leadership).
| Name | Role | Group |
|---|---|---|
Louis Nel | Co-Founder | Leadership |
Dawie De Bruin | Co-Founder | Leadership |
Paul Jonker | CEO | Leadership |
Complete people profiles for Brunel
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Brunel
2 dated milestones of Brunel across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Brunel is founded.
- Funding First funding round.
Competitors of Brunel
Brunel has 3 listed competitors in our database. They include Activo Health, Rand Pharmaceutical Distributors and Anmarate.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| activo.co.za | 2009 | Centurion, South Africa | Pharmaceutical products are distributed by Activo Health in South Africa. | |||
| randpharm.co.za | 2003 | Centurion, South Africa | Pharmaceutical products are distributed in South Africa by the company. | |||
| anmarate.co.za | 1996 | George, South Africa | R&D company focused on manufacturing of drugs for multiple therapeutic areas |
Detailed competitors of Brunel
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Brunel
The website of Brunel (brunel.co.za) receives about 16.2K visits a month.
- Monthly visits16.2K
▼ 48% vs previous month
Websites whose visitors overlap most with Brunel. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
in-the-box.co.za | in-the-box.co.za | 100% | #911,311 | – | |
imithiyesintu.co.za | imithiyesintu.co.za | 97% | #3,472,152 | – | |
sela.co.za | sela.co.za | 86% | #2,386,778 | – | |
bulkbodycare.co.za | bulkbodycare.co.za | 83% | #1,036,268 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Brunel
Brunel was founded in 1974 and raised its 1st funding round 48 years after it was founded.
Brunel is headquartered in Centurion, South Africa. It is registered at Centurion, Gauteng, South Africa.
Paul Jonker is the CEO of Brunel, as recorded in our data.
Brunel Laboratoria is established as a privately owned pharmaceutical company based in South Africa. The company is engaged in the production, distribution, and management of a wide range of healthcare brands and products. Solutions are provided across sectors including oral health, haircare, eye care, vitamins, sun protection, and probiotics. A custom-built distribution center is utilized to ensure efficient delivery from manufacturer to client. With over five decades of expertise, strategic partnerships are maintained to uphold quality and compliance in the supply chain.
Brunel's top competitors include Activo Health, Anmarate and Rand Pharmaceutical Distributors.
Brunel offers Healthcare Products, Packaging Solutions, and MYOPRIN 100 mg Tablets.
Brunel has 3 investors. Key investors include RMB Corvest, Calibre Capital, and Umoya Capital Partners.
Brunel operates through Brunel Laboratoria (Pty) Ltd.